BPTES is a potent and selective allosteric Glutaminase GLS1 (KGA) inhibitor with IC50 of 0.16 μM.

STF-31 is a novel potent and selective glucose transporter (GLUT1) inhibitor with IC50 of 1 μM.

Telaglenastat (formerly known as CB-839) is a novel, investigational, potent, selective, and orally bioavailable small molecule glutaminase inhibitor with IC50 of 24 nM for recombinant human GAC.

UPGL00004 (UPGL-00004) is a novel, potent and allosteric inhibitor of glutaminase C (GAC, kidney glutaminase isoform C) with anticancer activity.

Diazooxonorleucine is a novel and potent amino acid.

GLS-IN-968 is an allosteric inhibitor of glutaminase (GLS).

GK921 is a novel and potent inhibitor of transglutaminase 2 (TGase) with an IC50 of 7.71 μM for human recombinant TGase 2.

IPN-60090 ( IACS-6274; IPN60090) is a novel, potent, orally bioavailable and specific inhibitor of GLS1 (the kidney-type glutaminase), which is an important enzyme for metabolic energy production.